Time to Upgrade: Boosting Speed and Safety in Gene Therapy Quality Assurance

12/12/2023

sponsored by Bio-Rad Laboratories

The rapid pace of development in the field of gene therapy demands faster and more accurate methods for measuring the critical quality attributes and safety of these promising therapies.

Droplet Digital PCR (ddPCR) is a powerful tool that can provide absolute measurements of RNA and DNA, and is routinely used to precisely measure viral titer, HEK DNA quantity and size, and detect mycoplasma contamination.

In this session, we will discuss new innovations in ddPCR, including: Characterizing viral vector identity with highly multiplexed 6-color assays and higher order linkage analysis. Rapid 8-hour orthogonal methods for characterizing replication competent AAV or lentivirus. ddPCR is a versatile and powerful technology that is empowering the field of gene therapy manufacturing and quality assurance.

Join us to learn about the latest innovations in ddPCR and how they can help you bring new and safe gene therapies to market faster!

Requirements of replication competent virus testing
Different methods to test RCV
Importance of nucleic acid based testing for lot release

Available On-Demand

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.